SCIENTIFIC PROGRAM
INTENSIVE CARE IN LIVER DISEASES
PRESIDENT
L. Skladany
SCIENTIFIC COMMITTEE
T. Gustot, J.G. Abraldes, J.P. Arab, P. Jarcuska, V. LaMura, S. Sarin, E. Tsochatzis, R. Zahorec
and
S. Adamcova Selcanova, M. Belovicova, S. Drazilova, S. Hrusovsky, M. Janicko, T. Koller, P. Kristian, V. Kupcova, M. Oltman,
M. Rac, M. Szantova, I. Schreter, M. Zigrai
ORGANIZING COMMITTEE:
S. Adamcova Selcanova
P. Slovak
PRESIDENT
L. Skladany
SCIENTIFIC COMMITTEE
T. Gustot
J.G. Abraldes
J.P. Arab
P. Jarcuska
V. LaMura
S. Sarin
E. Tsochatzis
R. Zahorec
and
S. Adamcova Selcanova
M. Belovicova
S. Drazilova
S. Hrusovsky
M. Janicko
T. Koller
P. Kristian
V. Kupcova
M. Oltman
M. Rac
M. Szantova
I. Schreter
M. Zigrai
ORGANIZING COMMITTEE:
S. Adamcova Selcanova
P. Slovak
8.00 – 9.20: POSTER TOUR
CHAIRS: M. Janicko, T. Koller
—
9.30 – 9.40: WELCOME ADDRESS
L. Skladany, President of the Slovak Society of Hepatology
R. Zahorec, President of the Slovak Society of Anesthesiology and Intensive Medicine
—
09.45 – 13.20: SESSION 1
CHAIRS: T. Gustot, P. Jarcuska
09.45 – 10.05: P. Hegyi (HU). Translational medicine and liver intensive care
10.07 – 10.27: T. Gustot (BE). Futility and post-ICU pathways in ACLF
10.29 – 10.49: J.G. Abraldes (CA). Variceal bleeding as a trigger of ACLF
10.51 – 11.11: E. Tsochatzis (GB). ACLF: EASL/EF CLIF perspective
11.13 – 11.33: S. Sarin (IN). ACLF: APASL perspective
11.35 – 11.55: J.P. Arab (CL). ACLF: Time-frame and window of opportunity
11.57 – 12.17: V. LaMura (IT). Hemostasis in ACLF
12.19 – 12.39: L. Vitek (CZ). Plasmapheresis in ACLF from the angle of bilirubinology
12.40 – 12.50: Discussion
12.50 – 14.00: LUNCH
—
14.00 – 16.05: SESSION 2
CHAIRS: E. Tsochatzis, V. LaMura
14.00 – 14.15 T. Koller, D. Liska (SK). Frailty, sarcopenia and physiotherapy in liver critical care
14.17 – 14.32 P. Jarcuska (SK). Immunity in ACLF
14.34 – 14.49 M. Janicko (SK). Brain in ACLF
15.01 – 15.16 P. Faybik (AT). Lungs in ACLF
15.18 – 15.33 E. Honsova (CZ). Histology of ACLF
15.35 – 15.50 N. Bystrianska, D. Zilincanova (SK). Alcoholic hepatitis as a trigger of ACLF
15.50 – 16.00 Discussion
16.00 – 16.15: COFFEE BREAK
—
16.15 – 18.35: SESSION 3
CHAIRS: J.G. Abraldes, J.P. Arab
16.15 – 16.35: M. Papp (HU). ACLF: Central European perspective
16.37 – 16.57: I. Mikolasevic (HR). ACLF: When C stands for MAFLD
16.59 – 17.19: T. Milovanovic Alempijevic (RS). ACLF in women: any different?
17.21 – 17.41: I. Grgurevic (HR). COVID-19 as a trigger of ACLF
17.43 – 18.03: T. Filipec-Knizaj (HR). Nutrition in ACLF
18.05 – 18.25: M. Kukla (PL). Microbiome in ACLF
18.25 – 18.35: Discussion
19.30 – 00.00: DISCUSSION EVENING
08.30 – 09.45: SESSION 4
CHAIRS: I. Grgurevic, J. Sperl
08.30 – 08.45: J. Sperl (CZ). Hepatitis B as a trigger of ACLF
08.47 – 09.02: S. Frankova (CZ). HEV and other viruses as a triggers of ACLF
09.04 – 09.19: S. Drazilova (SK). ACLF in autoimmune liver syndromes
09.21 – 09.36: TBA. Kidneys and ACLF
09.37 – 09.45: Discussion
09.45 – 10.00: COFFEE BREAK
—
10.00 – 12.00 SESSION 5
CHAIRS: T. Filipec Knizaj, P. Trunecka
10.00 – 10.15: P. Trunecka (CZ). Liver transplantation for ACLF
10.17 – 10.32: M. Oliverius (CZ). Surgery as a trigger of ACLF
10.34 – 10.49: E. Kusikova (SK). Early postoperative care in ACLD and after LT
10.51 – 11.06: M. Rac (SK). Economy of liver ICU
11.08 – 11.15: Discussion
11.15 – 11.30: CLOSING REMARKS: P. Jarcuska
11.30 – 13.00: LUNCH
